Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewS-Sulfo-L-cysteine sodium salt
Description: Group I mGlu agonist
Biological Activity for S-Sulfo-L-cysteine sodium salt
S-Sulfo-L-cysteine sodium salt is an EAA receptor agonist. Agonist at mGlu1α and mGlu5a subtypes expressed in clonal RGT cell lines.
Technical Data for S-Sulfo-L-cysteine sodium salt
| M. Wt | 223.19 |
| Formula | C3H6NO5S2Na |
| Storage | Store at -20°C |
| CAS Number | 7381-67-1 |
| PubChem ID | 23675751 |
| InChI Key | DQFVBELGDROGDO-DKWTVANSSA-M |
| Smiles | [Na+].[H][C@](N)(CSS([O-])(=O)=O)C(O)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for S-Sulfo-L-cysteine sodium salt
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 100 |
Preparing Stock Solutions for S-Sulfo-L-cysteine sodium salt
The following data is based on the product molecular weight 223.19. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 4.48 mL | 22.4 mL | 44.8 mL |
| 5 mM | 0.9 mL | 4.48 mL | 8.96 mL |
| 10 mM | 0.45 mL | 2.24 mL | 4.48 mL |
| 50 mM | 0.09 mL | 0.45 mL | 0.9 mL |
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets for S-Sulfo-L-cysteine sodium salt
References for S-Sulfo-L-cysteine sodium salt
References are publications that support the biological activity of the product.
Kingston et al (1998) Sulphur-containing amino acids are agonists for group 1 metabotropic receptors expressed in clonal RGT cell lines. Neuropharmacology 37 277 PMID: 9681926
Mewett et al (1983) Pharmacology of the excitatory actions of sulphonic and sulphinic amino acids. CNS Receptors: From Molecular Pharmacology to Beha 163-174
If you know of a relevant reference for S-Sulfo-L-cysteine sodium salt, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: S-Sulfo-L-cysteine sodium salt, S-Sulfo-L-cysteine sodium salt supplier, Group, I, agonists, mGlur, Receptors, mGlu1, mGlu5, Glutamate, Metabotropic, mGluR1, mGluR5, (Metabotropic), 0162, Tocris Bioscience
Citations for S-Sulfo-L-cysteine sodium salt
Citations are publications that use Tocris products.
Currently there are no citations for S-Sulfo-L-cysteine sodium salt. Do you know of a great paper that uses S-Sulfo-L-cysteine sodium salt from Tocris? Please let us know.
Reviews for S-Sulfo-L-cysteine sodium salt
There are currently no reviews for this product. Be the first to review S-Sulfo-L-cysteine sodium salt and earn rewards!
Have you used S-Sulfo-L-cysteine sodium salt?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Metabotropic Glutamate Receptors Scientific Review
Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.
Addiction Poster
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Huntington's Disease Poster
Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.
Parkinson's Disease Poster
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.